Spontaneous Bacterial Peritonitis: An Uncommon Complication of Pulmonary Arterial Hypertension

Dandan Bhave^*
*Correspondence: Dandan Bhave, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, USA, Email:

Description

Spontaneous Bacterial Peritonitis (SBP) is a severe infection of the peritoneal cavity typically associated with chronic liver disease and ascites. Although rare, its occurrence in patients with Pulmonary Arterial Hypertension (PAH) raises important clinical considerations. This opinion article explores the potential link between PAH and SBP, highlights the diagnostic and management challenges, and advocates for greater awareness and research to address this rare but serious complication effectively. Pulmonary Arterial Hypertension (PAH) is a progressive condition characterized by elevated blood pressure in the pulmonary arteries, leading to right heart failure and a range of systemic effects. Complications of PAH can be numerous, affecting various organ systems. While SBP is classically associated with liver cirrhosis and ascites, the potential for this complication to arise in patients with PAH presents a unique clinical challenge. This article provides an opinion on the implications of SBP in the context of PAH, emphasizing the need for heightened awareness and improved management strategies [1].

SBP is a serious infection of the peritoneal cavity that occurs without an evident source of infection. It is most commonly seen in patients with cirrhosis and ascites, where bacteria from the gut translocate to the peritoneal space due to compromised immune defences. In cirrhotic patients, ascitic fluid accumulates due to portal hypertension and hepatic dysfunction, creating an environment prone to bacterial growth. The fluid’s high protein content and decreased complement activity make it a suitable medium for bacterial proliferation. Immune System Dysfunction: Chronic liver disease impairs immune function, increasing susceptibility to infections. This immune dysfunction is crucial in the development of SBP. Advanced PAH often leads to right heart failure, which can cause systemic venous congestion and ascites. Although not as pronounced as in liver disease, ascitic fluid accumulation in PAH patients could theoretically increase the risk of bacterial translocation and SBP [2].

Patients with PAH may receive immunosuppressive treatments, particularly if associated with connective tissue diseases. These therapies can further predispose individuals to infections, including SBP. Severe PAH patients may have compromised overall health and organ function, which can increase their susceptibility to infections and complicate their clinical management. Symptoms of SBP, such as abdominal pain, fever, and altered mental status, can be difficult to distinguish from those related to PAH and its complications. This overlap necessitates a high index of suspicion in PAH patients presenting with new abdominal symptoms. Diagnosis requires paracentesis to analyze ascitic fluid for white blood cell count, culture, and other parameters. In PAH patients, differentiating between ascites due to right heart failure and true bacterial infection can be challenging. Empirical broad-spectrum antibiotics should be initiated promptly. The choice of antibiotics may need to be adjusted based on culture results and patient-specific factors [3].

Management of PAH-related complications, such as right heart failure and ascites, should be optimized to support the overall treatment of SBP. Close monitoring is essential to ensure resolution of the infection and to manage any potential complications related to both SBP and PAH. Healthcare providers should be educated about the potential for SBP in PAH patients, particularly those with significant ascites or receiving immunosuppressive therapy. Developing screening protocols for at-risk PAH patients presenting with abdominal symptoms could facilitate early detection and treatment. Research into the mechanisms linking PAH with SBP could provide insights into prevention and treatment strategies. Trials investigating the incidence of SBP in PAH patients and evaluating optimal management strategies could help improve outcomes [4].

Spontaneous bacterial peritonitis, while uncommon in patients with pulmonary arterial hypertension, represents a serious complication that requires increased awareness and careful management. The indirect links between PAH and SBP, through mechanisms such as ascites and immunosuppressive therapies, highlight the need for vigilance in diagnosing and treating this condition. By improving clinical awareness, developing targeted research, and optimizing management strategies, healthcare providers can enhance the care and outcomes for PAH patients experiencing SBP [5].

Acknowledgement

None.

Conflict of Interest

None.

References

1. BA, Runyon. "Management of adult patients with ascites caused by cirrhosis." Hepatol 27 (1998): 264-272.

Google Scholar, Indexed at

2. Goh, Zhong Ning Leonard, Roland Yii Lin Teo, Bui Khiong Chung and Alexis Ching Wong, et al. "At the heart of the problem: Congestive cardiac failure as a cause of ascites: A narrative review." Med 101 (2022): e29951.

Google Scholar, Crossref, Indexed at

3. Such, Jose and Bruce A. Runyon. "Spontaneous bacterial peritonitis." Clin Infect Dis (1998): 669-674.

Google Scholar, Indexed at

4. Canakis, Andrew, Justin Canakis, Minisha Lohani and Thomas Ostrander. "Spontaneous bacterial peritonitis in cardiac ascites: A rare but deadly occurrence." Am J Case Rep 20 (2019): 1446.

Google Scholar, Crossref, Indexed at

5. Shaked, Yechiel and Yecheskel Samra. "Primary pneumococcal peritonitis in patients with cardiac ascites: Report of 2 cases." Cardiology 75 (1988): 372-374.

Google Scholar, Crossref, Indexed at